What is the recommended first‑line treatment for classic scabies, including dosing and application details for infants, children, and crusted scabies, and what are the second‑line options if permethrin is unavailable or contraindicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Scabies Treatment

Permethrin 5% cream applied to all areas of the body from the neck down and washed off after 8-14 hours is the first-line treatment for classic scabies in all age groups, including infants and children. 1, 2

First-Line Treatment: Permethrin 5%

Application Details

  • Apply to entire body from neck down (including under fingernails, between fingers and toes, wrists, elbows, armpits, genitals, and buttocks) 2
  • Special consideration for infants and young children: Apply to scalp, hairline, temple, and forehead as well, since these areas are commonly infested in this age group 1, 2
  • Duration: Leave on for 8-14 hours before washing off 1, 2
  • Amount: Approximately 30 grams for an average adult 2
  • One application is generally curative 2

Why Permethrin First?

Permethrin is effective, safe, and less expensive than ivermectin 1. The FDA label confirms it is safe and effective in pediatric patients two months of age and older 2. However, recent evidence from 2024 shows concerning treatment failure rates with permethrin (only 27% cure rate in one randomized trial), suggesting possible emerging resistance 3.

Alternative First-Line Option: Oral Ivermectin

Ivermectin 200 mcg/kg orally, repeated in 2 weeks 1

Key Points About Ivermectin

  • Must be repeated at 2 weeks due to limited ovicidal activity 1
  • Take with food to increase bioavailability and epidermal penetration 1
  • Not recommended for children <15 kg due to insufficient safety data 1
  • One study showed increased mortality in elderly, debilitated persons, though not confirmed in subsequent reports 1
  • Safe in renal impairment; caution with severe liver disease 1

Second-Line Treatment Options

When Permethrin/Ivermectin Unavailable or Failed

Lindane 1% lotion or cream applied from neck down, washed off after 8 hours 1

Critical Lindane Contraindications and Warnings

  • Never use in children <10 years old 1
  • Never use immediately after bathing (seizure risk) 1
  • Avoid in extensive dermatitis (increased absorption → neurotoxicity) 1
  • Avoid in pregnancy (neural tube defects, mental retardation risk) 1
  • Associated with seizures and aplastic anemia 1
  • Resistance reported in some U.S. regions 1

Crusted (Norwegian) Scabies Treatment

Combination therapy is mandatory for crusted scabies due to high mite burden and treatment failure risk with monotherapy 1

Recommended Regimen

  • Topical permethrin 5% cream: Full-body application daily for 7 days, then twice weekly until cure 1
  • PLUS oral ivermectin 200 mcg/kg: Days 1,2,8,9, and 15 1
  • Additional ivermectin on days 22 and 29 may be needed for severe cases 1
  • Never use lindane in crusted scabies (neurotoxicity risk with denuded skin) 1

Special Populations

Infants and Young Children

  • Permethrin is preferred 1
  • Include scalp, temple, forehead in application 1, 2
  • Ivermectin safety not established in children <15 kg 1

Pregnancy and Lactation

  • Permethrin is the preferred treatment 1
  • Ivermectin classified as "human data suggest low risk" but limited data in pregnancy 1
  • Never use lindane (teratogenic) 1

HIV/Immunocompromised

  • Uncomplicated scabies: Same treatment as immunocompetent patients 1
  • Higher risk for crusted scabies - requires specialist consultation 1

Essential Adjunctive Measures

Environmental Decontamination

  • Machine-wash and dry bedding/clothing on hot cycle OR dry clean OR remove from body contact for 72 hours 1
  • Fumigation is unnecessary 1

Contact Management

  • Treat all sexual, close personal, or household contacts within the previous month 1
  • Contacts should be treated even if asymptomatic 1

Follow-Up and Treatment Failure

Pruritus may persist up to 2 weeks after successful treatment - this is NOT treatment failure 1

Retreatment Indicated When:

  • Living mites observed after 14 days 2
  • Symptoms persist >2 weeks with new burrows 1
  • Consider retreatment at 2 weeks if symptomatic 1
  • Use alternative regimen if initial treatment fails 1

Common Pitfalls to Avoid

  1. Incomplete application: Must cover entire body including web spaces, under nails, genitals
  2. Inadequate contact time: Full 8-14 hours required for permethrin
  3. Missing the second ivermectin dose at 2 weeks
  4. Failing to treat asymptomatic contacts (leads to reinfection)
  5. Inadequate environmental decontamination
  6. Retreating too early for persistent itch (allergic dermatitis can persist 2 weeks)
  7. Using lindane in high-risk populations (children, pregnancy, extensive dermatitis)

Emerging Concerns

Recent 2024 evidence suggests permethrin resistance may be developing, with cure rates as low as 27% in one randomized trial compared to 87% for benzyl benzoate 3. While permethrin remains guideline-recommended first-line therapy, clinicians should maintain high suspicion for treatment failure and have a low threshold for switching to alternative regimens or combination therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.